Juan José González Ferrer-rekin lankidetzan egindako argitalpenak (10)

2021

  1. Influence of Baseline Physical Activity as a Modifying Factor on COVID-19 Mortality: A Single-Center, Retrospective Study

    Infectious Diseases and Therapy, Vol. 10, Núm. 2, pp. 801-814

2014

  1. Selected CD133+ progenitor cells to promote angiogenesis in patients with refractory angina final results of the PROGENITOR randomized trial

    Circulation Research, Vol. 115, Núm. 11, pp. 950-960

  2. The COR trial: A randomized study with continuous rhythm monitoring to compare the efficacy of cryoenergy and radiofrequency for pulmonary vein isolation

    Heart Rhythm, Vol. 11, Núm. 1, pp. 8-14

2012

  1. Subacute tuberculous constrictive pericarditis

    Journal of the American College of Cardiology, Vol. 59, Núm. 11

2011

  1. Can resistance to aspirin be reversed after an additional dose?

    Journal of Thrombosis and Thrombolysis, Vol. 32, Núm. 3, pp. 356-361

  2. Diaphragm paralysis due to pseudoaneurysm of internal mammary artery after pacemaker implantation

    Europace, Vol. 13, Núm. 4, pp. 592-593

2010

  1. Mild heart failure is a mortality marker after a non-ST-segment acute myocardial infarction

    European Journal of Internal Medicine, Vol. 21, Núm. 5, pp. 439-443

  2. Prognostic Implications of Bundle Branch Block in Patients Undergoing Primary Coronary Angioplasty in the Stent Era

    American Journal of Cardiology, Vol. 105, Núm. 9, pp. 1276-1283

2008

  1. Pronóstico intrahospitalario de la hemoglobina en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 61, Núm. 9, pp. 945-952

  2. Valor pronóstico de la primera glucemia en ayunas en comparación con la glucemia al ingreso en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 61, Núm. 5, pp. 458-464